Myths vs. Facts: Getting Oxbryta (Voxelotor) Covered by Aetna in Illinois - What Patients Need to Know
Answer Box: Oxbryta Coverage Reality in Illinois
Critical Update: Oxbryta (voxelotor) was voluntarily withdrawn from the U.S. market by Pfizer in September 2024 due to safety concerns. Claims are now denied due to loss of FDA approval. Illinois patients with sickle cell disease should work with their healthcare providers